Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

COLLEGIUM PHARMACEUTICAL, INC

COLL · Nasdaq · CIK 0001267565 · Healthcare · Drug Manufacturers—Specialty & Generic

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

14 Form 4 transaction lines observed in the same window
4 sales · 10 option, withholding, award, gift or other lines

Last qualifying purchaseNo qualifying purchase is present in the local Form 4 history.

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesModerate
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Freund John GordonDirector
○○▼▼
BOHLIN GAREN GDirector
○▼○
SANTINI GINODirector
○○
Lurker NancyDirector
▼○
Glancy Donovan MichaelDirector
○
Paya Carlos VDirector
○
● Purchase▼ Sale○ Other

Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot.—

Recent Form 4 activity

0Purchases
14Sales
32Other Form 4 lines
24SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING4 sale line(s) · context only
OTHER10 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
5,516,880
Previous report
5,675,115
Avg daily volume
910,922
Days to cover
6.1

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

No qualifying code P equity purchase is present in the local Form 4 history.

Form 4 evidence

46 transaction lines in the latest 365-day window; 417 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-08SANTINI GINOOption exercise / conversion (M)Common Stock8,700USD 16.49USD 143,463SEC filing ↗
2026-05-18Freund John GordonSale (S)Common Stock20USD 34.05USD 681SEC filing ↗
2026-05-15Freund John GordonSale (S)Common Stock4,127USD 34.54USD 142,547SEC filing ↗
Show recent Form 4 evidence (30 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-06-08SANTINI GINOOption exercise / conversion (M)Common Stock8,700USD 16.49USD 143,463SEC filing ↗
2026-05-18Freund John GordonSale (S)Common Stock20USD 34.05USD 681SEC filing ↗
2026-05-15Freund John GordonSale (S)Common Stock4,127USD 34.54USD 142,547SEC filing ↗
2026-05-15Freund John GordonOption exercise / conversion (M)Common Stock8,700USD 16.49USD 143,463SEC filing ↗
2026-05-14SANTINI GINOAward / grant (A)Common Stock8,741USD 0.00USD 0SEC filing ↗
2026-05-14Paya Carlos VAward / grant (A)Common Stock8,741USD 0.00USD 0SEC filing ↗
2026-05-14Lurker NancyAward / grant (A)Common Stock8,741USD 0.00USD 0SEC filing ↗
2026-05-14Glancy Donovan MichaelAward / grant (A)Common Stock17,482USD 0.00USD 0SEC filing ↗
2026-05-14Freund John GordonAward / grant (A)Common Stock8,741USD 0.00USD 0SEC filing ↗
2026-05-14Balice-Gordon Rita J.Award / grant (A)Common Stock8,741USD 0.00USD 0SEC filing ↗
2026-05-14BOHLIN GAREN GAward / grant (A)Common Stock8,741USD 0.00USD 0SEC filing ↗
2026-05-13Lurker NancySale (S)Common Stock4,500USD 35.97USD 161,865SEC filing ↗
2026-05-11BOHLIN GAREN GSale (S)Common Stock8,700USD 37.18USD 323,466SEC filing ↗
2026-05-11BOHLIN GAREN GOption exercise / conversion (M)Common Stock8,700USD 16.49USD 143,463SEC filing ↗
2026-03-18Dieter DavidSale (S)Common Stock13,976USD 34.92USD 488,042SEC filing ↗
2026-03-09Dieter DavidSale (S)Common Stock6,224USD 36.65USD 228,110SEC filing ↗
2026-03-03Dreyer ScottSale (S)Common Stock49,976USD 40.40USD 2,019,274SEC filing ↗
2026-02-10Tupper ColleenTax withholding (F)Common Stock38,540USD 46.75USD 1,801,745SEC filing ↗
2026-02-10Tupper ColleenAward / grant (A)Common Stock59,155USD 0.00USD 0SEC filing ↗
2026-02-10Smith Thomas BTax withholding (F)Common Stock17,435USD 46.75USD 815,086SEC filing ↗
2026-02-10Smith Thomas BAward / grant (A)Common Stock37,042USD 0.00USD 0SEC filing ↗
2026-02-10Karnani VikramTax withholding (F)Common Stock11,296USD 46.75USD 528,088SEC filing ↗
2026-02-10Karnani VikramAward / grant (A)Common Stock111,795USD 0.00USD 0SEC filing ↗
2026-02-10Dreyer ScottTax withholding (F)Common Stock31,592USD 46.75USD 1,476,926SEC filing ↗
2026-02-10Dreyer ScottAward / grant (A)Common Stock49,725USD 0.00USD 0SEC filing ↗
2026-02-10Dieter DavidTax withholding (F)Common Stock2,781USD 46.75USD 130,012SEC filing ↗
2026-02-10Dieter DavidAward / grant (A)Common Stock31,199USD 0.00USD 0SEC filing ↗
2025-12-08Dreyer ScottSale (S)Common Stock17,600USD 48.17USD 847,850SEC filing ↗
2025-12-08Dreyer ScottOption exercise / conversion (M)Common Stock17,600USD 15.90USD 279,840SEC filing ↗
2025-12-05Balice-Gordon Rita J.Sale (S)Common Stock3,650USD 47.03USD 171,660SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerCOLL
CIK0001267565
SectorHealthcare
IndustryDrug Manufacturers—Specialty & Generic Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history417 transaction lines from 2020-01-02 to 2026-06-08
0 P purchase lines · 133 S sale lines · 284 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.